Skip to main content
S

Suzhou Highfine Biotech Co., Ltd. — Investor Relations & Filings

Ticker · 301393 Shenzhen Stock Exchange Manufacturing
Filings indexed 392 across all filing types
Latest filing 2026-05-08 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 301393

About Suzhou Highfine Biotech Co., Ltd.

https://www.highfine.com

Suzhou Highfine Biotech Co., Ltd. is a specialized manufacturer and supplier of high-quality biochemical reagents and chemical building blocks. The company focuses on the research, development, and large-scale production of peptide synthesis reagents, protected amino acids, and linkers for antibody-drug conjugates (ADCs). Its core product portfolio includes coupling reagents, Fmoc and Boc-protected amino acids, and various PEG derivatives. Highfine Biotech serves a global clientele comprising pharmaceutical corporations, biotechnology enterprises, and academic research institutions. By leveraging advanced synthesis technologies and rigorous quality control standards, the company provides essential materials for drug discovery and development. Its expertise extends to custom synthesis services, catering to specific molecular requirements for complex chemical synthesis and therapeutic research.

Recent filings

Filing Released Lang Actions
国联民生证券承销保荐有限公司关于苏州昊帆生物股份有限公司2025年度跟踪报告
Regulatory Filings
2026-05-08 Chinese
上海市广发律师事务所关于苏州昊帆生物股份有限公司2025年度股东会的法律意见书
Regulatory Filings
2026-05-08 Chinese
2025年度股东会决议公告
Regulatory Filings
2026-05-08 Chinese
2025年度独立董事述职报告(徐小平)
Regulatory Filings
2026-04-16 Chinese
2025年度内部控制评价报告
Regulatory Filings
2026-04-16 Chinese
2025年度募集资金存放、管理与使用情况的专项报告
Regulatory Filings
2026-04-16 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.